April 15, 2021
A Persistent Shortfall in TB Research and Development Funding
Statement on 2020 G-FINDER Report March 25, 2021
STAND Clinical Trial Results Published
March 24, 2021
TB Alliance Welcomes Drug-Resistant TB Survivors to Access Advisory Committee
Dr. Zolelwa Sifumba and Dr. Saurabh Rane to Help Increase Access to Urgently Needed Improved TB Treatments March 24, 2021
Amid Global Pandemic, TB Treatment Innovation Advances at an Unprecedented Pace
Presentation at CROI highlights the durability and response to new treatment for highly drug-resistant tuberculosis. March 24, 2021
TB Alliance Congratulates MSF on TB-PRACTECAL Milestone
March 23, 2021
TB Alliance Issues Call for Researchers to Access TB Biomarker Repository
Researchers Invited to Access MARK-TB Library of Samples from Clinical Trials March 18, 2021
TB Alliance and GSK announce partnership to develop new TB therapeutics
Partnership between pharmaceutical firm and non-profit product development partnership seeks to identify and advance new compounds to achieve breakthroughs in TB treatment February 1, 2021
ZebiAI and TB Alliance Announce Collaboration to Apply ML-Driven Discovery Platform to Tuberculosis Targets
TB Alliance to leverage ZebiAI’s platform to discover novel probe compounds for important tuberculosis targets, with options for drug discovery January 28, 2021